CN116590279A - 一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 - Google Patents
一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 Download PDFInfo
- Publication number
- CN116590279A CN116590279A CN202310463323.3A CN202310463323A CN116590279A CN 116590279 A CN116590279 A CN 116590279A CN 202310463323 A CN202310463323 A CN 202310463323A CN 116590279 A CN116590279 A CN 116590279A
- Authority
- CN
- China
- Prior art keywords
- centrifuge tube
- solution
- magnetic beads
- kit
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011324 bead Substances 0.000 title claims abstract description 74
- 102000053602 DNA Human genes 0.000 title claims abstract description 42
- 108020004414 DNA Proteins 0.000 title claims abstract description 42
- 125000002887 hydroxy group Chemical group [H]O* 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000009089 cytolysis Effects 0.000 claims abstract description 29
- 238000002156 mixing Methods 0.000 claims abstract description 27
- 239000006166 lysate Substances 0.000 claims abstract description 13
- 108010067770 Endopeptidase K Proteins 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims description 46
- 239000000872 buffer Substances 0.000 claims description 21
- 239000007853 buffer solution Substances 0.000 claims description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- 239000003480 eluent Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 229920004890 Triton X-100 Polymers 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims description 6
- 229910021645 metal ion Inorganic materials 0.000 claims description 6
- 239000004005 microsphere Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 238000001179 sorption measurement Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000007984 Tris EDTA buffer Substances 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims description 3
- 238000011010 flushing procedure Methods 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 42
- 102000039446 nucleic acids Human genes 0.000 abstract description 33
- 108020004707 nucleic acids Proteins 0.000 abstract description 33
- 150000007523 nucleic acids Chemical class 0.000 abstract description 33
- 238000001514 detection method Methods 0.000 abstract description 17
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 101710163270 Nuclease Proteins 0.000 abstract description 4
- 238000012408 PCR amplification Methods 0.000 abstract description 4
- 230000006037 cell lysis Effects 0.000 abstract description 4
- 239000003112 inhibitor Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000012535 impurity Substances 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 abstract description 3
- 238000004321 preservation Methods 0.000 abstract description 2
- 210000002381 plasma Anatomy 0.000 description 34
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 9
- 239000012634 fragment Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 241001504639 Alcedo atthis Species 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
- 229940043264 dodecyl sulfate Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- -1 salt ions Chemical class 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
浓度ng/ul | 实验组-CWE240提取 | 对比组-Kingfisher提取 |
样本1 | 0.125 | 0.0448 |
样本2 | 0.123 | 0.0424 |
样本3 | 0.166 | 0.0564 |
样本4 | 0.172 | 0.069 |
含量 | 实验组-CWE240提取 | 对比组-Kingfisher提取 |
样本1 | 54 | 27.2 |
样本2 | 40 | 34 |
样本3 | 59.6 | 24.8 |
样本4 | 60.8 | 30.4 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310463323.3A CN116590279A (zh) | 2023-04-26 | 2023-04-26 | 一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310463323.3A CN116590279A (zh) | 2023-04-26 | 2023-04-26 | 一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116590279A true CN116590279A (zh) | 2023-08-15 |
Family
ID=87610719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310463323.3A Pending CN116590279A (zh) | 2023-04-26 | 2023-04-26 | 一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116590279A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117586952A (zh) * | 2024-01-19 | 2024-02-23 | 首都医科大学宣武医院 | 一种分离血浆外泌体的分离试剂及分离方法 |
-
2023
- 2023-04-26 CN CN202310463323.3A patent/CN116590279A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117586952A (zh) * | 2024-01-19 | 2024-02-23 | 首都医科大学宣武医院 | 一种分离血浆外泌体的分离试剂及分离方法 |
CN117586952B (zh) * | 2024-01-19 | 2024-04-26 | 首都医科大学宣武医院 | 一种分离血浆外泌体的分离试剂及分离方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7354327B2 (ja) | 生体液からの細胞外小胞の単離及びセルフリーdnaの同時単離のための自動及び手動方法 | |
US10954507B2 (en) | Method for isolating RNA with high yield | |
Brawerman | [56] The isolation of messenger RNA from mammalian cells | |
US11253797B2 (en) | Chromatographic device and method for isolating and purifying nucleic acids | |
US20070031880A1 (en) | Chemical treatment of biological samples for nucleic acid extraction and kits therefor | |
CN102776173B (zh) | 使用聚多卡醇和衍生物的核酸分离 | |
US20150299769A1 (en) | Method for lysing a fixed biological sample | |
CN116590279A (zh) | 一种基于羟基磁珠提取血浆游离dna的试剂盒及使用方法 | |
US11981893B2 (en) | DNA stabilization of RNA | |
CN105120986A (zh) | 用于核酸纯化的一步程序 | |
JP2013523144A (ja) | 核酸の存在下で陰イオン界面活性剤イオンを沈殿させるための方法 | |
US20170121705A1 (en) | Methods and kits for nucleic acid isolation | |
CN116376896A (zh) | 一种提取血浆游离dna的试剂盒、制备方法及提取方法 | |
JP2020531001A (ja) | パラフィン包埋試料から核酸を抽出するための方法およびキット | |
WO2009040444A1 (en) | Rna isolation method | |
CN112625857A (zh) | 一种游离核酸提取自动化机台及游离核酸提取试剂盒 | |
CN116355893B (zh) | 一种磁珠法核酸提取试剂盒及其应用 | |
JP3922420B2 (ja) | 改良されたリボ核酸の単離方法 | |
RU2808832C1 (ru) | Способ выделения рибонуклеиновой кислоты вируса из спинномозговой жидкости для молекулярно-биологических исследований | |
RU2736224C2 (ru) | Способ экспресс-выделения геномной днк для клинических исследований | |
WO2023242964A1 (ja) | 核酸溶離液及び当該核酸溶離液を用いた核酸の溶離方法 | |
Corbin | A Comparison of Collection Materials and Differential DNA Extraction Methods Used to Extract Sperm and Buccal Cell Mixtures | |
Tran | Co-extraction methods of DNA and total RNA for body fluid identification: A review | |
CN116200381A (zh) | 一种血浆游离dna提取试剂盒及提取方法和应用 | |
CN116904442A (zh) | 一种高灵敏血浆游离核酸提取试剂盒、提取方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Country or region after: China Address after: No. 18 Zelan Road, Medical High tech Zone, Taizhou City, Jiangsu Province, 225300 Applicant after: Jiangsu Kangwei century Biotechnology Co.,Ltd. Applicant after: Kangwei Medical Laboratory (Taizhou) Co.,Ltd. Address before: 225300 4 floor, building TQB, No. 1, Yao Cheng Avenue, Taizhou, Jiangsu. Applicant before: Jiangsu Kangwei century Biotechnology Co.,Ltd. Country or region before: China Applicant before: Taizhou Jianwei medical laboratory Co.,Ltd. |